abstract |
The pharmaceutical composition for transderminating under ca) contains a polymeric release matrix capable of forming a flexible film upon drying, selected from the group consisting of polymers and copolymers of cellulose, b) inorganic, c) 15 and 30 d) a physiologically suitable non-aqueous solvent capable of dissolving the release matrix, the agent and the transcutaneous promoter, and capable of rapidly removing the evaporation agent; with skin, wherein the transcutaneous absorption promoter is selected from the group consisting of an aliphatic fatty acid ester of the formula RCOOR.sub.1, wherein R.sub.2.sub.2-17.in alkyl or C.sub.2-17.n.alkenyl, R.sub.1.n. C.alpha.-C.sub.3 alkyl or -CH.sub.2 -CH.sub.2-O- (CH.sub.2.d.sub.2). -O-CH.sub.2.n.-CH.sub.3, n. the fatty acid ester contains at least 10 C and maximum two hydroxyl groups and an aliphatic fatty alcohol of the general formula R @ 2 as OH, wherein R @ 2 is. C.sub.10-20.n.alkyl. |